Alpár Horváth

Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients

Alpár Horváth, Imre Balásházy, Gábor Tomisa et al. · European Journal of Pharmaceutical Sciences · 2017 · 58 citations

Medicine, Pharmacokinetics, Pharmacology +16

Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort® Turbuhaler® dry powder fixed combination aerosol drug

Árpád Farkas, Ágnes Jókay, Imre Balásházy et al. · European Journal of Pharmaceutical Sciences · 2016 · 36 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler® dry powder inhaler

Árpád Farkas, David Lewis, Tanya Church et al. · International Journal of Pharmaceutics · 2017 · 31 citations · Full text

Pharmacy, Pharmacology, Drug Delivery +15

Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments

Veronika Groma, Szilvia Kugler, Árpád Farkas et al. · Scientific Reports · 2023 · 30 citations · Full text

Public Health, Infectious Diseases, Microbiology +16

Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients

Alpár Horváth, Árpád Farkas, Annamária Szipőcs et al. · European Journal of Pharmaceutical Sciences · 2020 · 28 citations · Full text

Medicine, Pharmacology, Pharmacokinetic-pharmacodynamic Modeling +16